Clinical Trial: Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children

U.S., Sept. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07188779) titled 'Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children' on Sept. 16.

Brief Summary: The purpose of the research is to determine if RADA16 (also known as PuraStat(R), PuraGel(R), or PuraSinus(R)) improves patient outcomes following pediatric tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage.Participants will:

Undergo tonsillectomy procedure. Receive and fill out a survey sent via email every 2 days following their procedure for 15 days, plus an additional survey on day 30, and track their symptoms. ...